DICE Therapeutics Inc. (DICE)
NASDAQ: DICE
· Real-Time Price · USD
47.55
0.03 (0.06%)
At close: Aug 08, 2023, 10:00 PM
DICE Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Cash & Equivalents | 73.46M | 101.59M | 461.39M | 48.27M | 16.77M | 53.67M | 115.83M | 311.61M | 15.51M |
Short-Term Investments | 454.92M | 452.95M | 112.83M | 218.34M | 265.45M | 249.56M | 203.5M | 24.05M | 26.96M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.62M | 198K | 198K | 669K | 752K | 198K | 198K | 198K | 1.5M |
Receivables | n/a | n/a | n/a | n/a | 1.5M | 2M | 2M | 2M | 2M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.92M | 4.8M | 3.54M | 1.22M | 1.16M | n/a | n/a | n/a | n/a |
Total Current Assets | 532.3M | 559.35M | 577.76M | 267.84M | 284.88M | 307M | 323.91M | 340.79M | 45.07M |
Property-Plant & Equipment | 16.75M | 16.06M | 16.02M | 16.49M | 16.95M | 17.41M | 1.65M | 1.4M | 1.46M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 18.37M | 16.25M | 16.22M | 17.16M | 17.7M | 17.61M | 1.84M | 1.59M | 2.95M |
Total Assets | 550.67M | 575.6M | 593.98M | 284.99M | 302.58M | 324.61M | 325.75M | 342.38M | 48.02M |
Account Payables | 3.41M | 4.12M | 3.08M | 1.39M | 1.96M | 4.75M | 1.71M | 4.11M | 1.84M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 1.53M | 1.48M | 1.42M | 1.37M | 1.32M | 1.89M | 480K | 245K | 33K |
Other Current Liabilities | 15.62M | 11.64M | 10.65M | 8.9M | 8.78M | 8.15M | 8.69M | 8.37M | 3.7M |
Total Current Liabilities | 20.57M | 17.24M | 15.15M | 11.66M | 12.07M | 14.79M | 10.88M | 12.72M | 5.57M |
Long-Term Debt | 11.05M | 11.46M | 11.84M | 12.21M | 12.58M | 14.65M | 1.92M | 2.12M | 2.34M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 8K | 20K | 108M |
Total Long-Term Liabilities | 11.05M | 11.46M | 11.84M | 12.21M | 12.58M | 14.65M | 1.92M | 2.14M | 110.34M |
Total Liabilities | 31.62M | 28.7M | 26.99M | 23.88M | 24.65M | 29.44M | 12.8M | 14.86M | 115.91M |
Total Debt | 12.58M | 12.94M | 13.27M | 13.59M | 13.9M | 16.53M | 2.4M | 2.37M | 2.37M |
Common Stock | 5K | 5K | 5K | 4K | 4K | 4K | 4K | 4K | n/a |
Retained Earnings | -248.06M | -213.24M | -187.59M | -164.37M | -143.82M | -122.3M | -103.71M | -87.51M | -70.18M |
Comprehensive Income | 2K | -297K | -597K | -1.32M | -1.58M | -1.14M | -58K | -2K | n/a |
Shareholders Equity | 519.06M | -213.24M | -187.59M | 261.11M | 277.94M | 295.17M | -103.71M | 327.52M | -67.89M |
Total Investments | 454.92M | 452.95M | 112.83M | 218.34M | 265.45M | 249.56M | 203.5M | 24.05M | 26.96M |